Key facts
- This page summarizes Andrew Ratz's Form 3 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2026, 17:56.
Andrew Ratz - 15 Mar 2026 Form 3 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)
- Reporting relationship
- Chief Technical Operations Off
- Issuer ticker
- NBIX
- Reported as of
- 15 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Darin Lippoldt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Andrew Ratz filed Form 3 for NEUROCRINE BIOSCIENCES INC (NBIX) on 17 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002117222
Primary reporting owner
Ratz Andrew
- Relationship
- Chief Technical Operations Off
- Address
- 6027 EDGEWOOD BEND CT., SAN DIEGO
- Signature
- /s/ Darin Lippoldt, Attorney-in-Fact
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NBIX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,018
- Date
- 15 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NBIX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,997
- Exercise price
- Footnotes
- F1, F2
NBIX
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,640
- Exercise price
- Footnotes
- F2, F3
NBIX
holding
Derivative
Incentive Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,664
- Exercise price
- $150.10
- Footnotes
- F4
NBIX
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,724
- Exercise price
- $150.10
- Footnotes
- F4
NBIX
holding
Derivative
Incentive Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 805
- Exercise price
- $124.12
- Footnotes
- F5
NBIX
holding
Derivative
Non-Qualified Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,348
- Exercise price
- $124.12
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents Restricted Stock Units (RSUs) remaining outstanding as of March 15, 2026. The RSU vested and settled as to 1/4 of the total units on February 3, 2026. The remaining RSUs vest annually at 1/4 of the total units subject to the award vesting on each of February 3, 2027, February 3, 2028, and February 3, 2029.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
The RSUs will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030.
Footnote F4
Represents option of which 1/4th of the shares underlying the option became vested and exercisable on February 3, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
Footnote F5
Represents option of which 1/48th of the shares underlying the option became vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.